<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02852915</url>
  </required_header>
  <id_info>
    <org_study_id>LapT4</org_study_id>
    <nct_id>NCT02852915</nct_id>
  </id_info>
  <brief_title>Laparoscopic Surgery for T4 Tumor of the Colon Cancer</brief_title>
  <official_title>Laparoscopic Surgery for T4 Tumor of the Colon Cancer: A Prospective, Multi-Center, Randomized, Open-Label, Parallel Group Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LI XIN-XIANG</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the short- and long-term survival of laparoscopic&#xD;
      surgery and conventional open surgery for T4 colon cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators previous study indicated that laparoscopic surgery is feasible in T4 colon&#xD;
      cancers with comparable clinical and oncologic outcomes. Laparoscopy can be considered as an&#xD;
      alternative approach for T4 colon cancers with the advantage of faster recovery. However, the&#xD;
      clinical value of laparoscopic surgery for T4 colon cancer was only validated in some&#xD;
      retrospective study and some prospective study in single institute with small sample of&#xD;
      patients. The aim of the present study is to compare the short-and long-term survival&#xD;
      outcomes of laparoscopic surgery and conventional open surgery for T4 colon cancer as well as&#xD;
      the mortality and the morbidity.&#xD;
&#xD;
      The number of patients needed to get a 80% power is 1960. The average number of&#xD;
      patients/surgical center is approximately 200 in each of 10 surgical centers.&#xD;
&#xD;
      The preoperative, intraoperative and postoperative period will be in complete accordance with&#xD;
      the usual care of the center.&#xD;
&#xD;
      The baseline demographics and conditions as well as the perioperative items and the&#xD;
      postoperative occurrences will be recorded through a prior designed e-questionnaire.&#xD;
&#xD;
      Systematically analyze and compare the disease free survival rate, the mortality, the&#xD;
      morbidity, and the proportion of completion of laparoscopic surgery of the two surgical&#xD;
      strategies (laparoscopy VS conventional open surgery).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2024</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>3-year</time_frame>
    <description>calculated from the date of surgery to the date of recurrence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>3-year</time_frame>
    <description>calculated from the date of diagnosis to the date of death from any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events (mortality and morbidity)</measure>
    <time_frame>3-month</time_frame>
    <description>Number of participants with treatment-related adverse events assessed by CTCAE v4.0</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1960</enrollment>
  <condition>Colonic Neoplasms</condition>
  <arm_group>
    <arm_group_label>Laparoscopic surgery for T4 colon cancers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic surgery for T4 colon cancers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional open surgery for T4 colon cancers</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conventional open surgery for T4 colon cancers</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic surgery</intervention_name>
    <description>Laparoscopic surgery for T4 cancer</description>
    <arm_group_label>Laparoscopic surgery for T4 colon cancers</arm_group_label>
    <other_name>Laparoscopic surgery for T4 colon cancers</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to provide written informed consent&#xD;
&#xD;
          -  Histologically confirmed diagnosis of colon carcinoma&#xD;
&#xD;
          -  CT or MRI verified as T4 colon cancer without involvement of other organs&#xD;
&#xD;
          -  Without multiple lesion other than carcinoma in situ&#xD;
&#xD;
          -  Tumor size &lt; 8 cm&#xD;
&#xD;
          -  No bowel obstruction&#xD;
&#xD;
          -  Sufficient organ function&#xD;
&#xD;
          -  No history of gastrointestinal surgery&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Performance Status (ECOG) 0, 1 or 2 and life expectancy &gt; 12 weeks&#xD;
&#xD;
          -  Operable patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women who are pregnant (confirmed by serum b-HCG in women of reproductive age) or&#xD;
             breast feeding&#xD;
&#xD;
          -  Unstable or uncompensated respiratory or cardiac disease&#xD;
&#xD;
          -  Serious active infections&#xD;
&#xD;
          -  Hypersensitivity to capecitabine/fluorouracil or oxaliplatin&#xD;
&#xD;
          -  Stomatitis, ulceration in the mouth or gastrointestinal tract&#xD;
&#xD;
          -  Severe diarrhea&#xD;
&#xD;
          -  Peripheral sensory neuropathy with functional impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xinxiang Li, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xinxiang Li, MD,PhD</last_name>
    <phone>86-13918176716</phone>
    <email>lxx1149@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qingguo Li, MD,PhD</last_name>
    <phone>86-18918298120</phone>
    <email>13111230016@fudan.edu.cn</email>
  </overall_contact_backup>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>July 21, 2016</study_first_submitted>
  <study_first_submitted_qc>July 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2016</study_first_posted>
  <last_update_submitted>August 3, 2016</last_update_submitted>
  <last_update_submitted_qc>August 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>LI XIN-XIANG</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Colonic Neoplasms</keyword>
  <keyword>Laparoscopic Surgery</keyword>
  <keyword>T4</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

